Managbanag, Roberto .

HRN: 29-06-26  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/24/2026
05/31/2026
IV
2.25G
Q8H
UROSEPSIS
Checking Initial Appropriateness 
05/27/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/27/2026
06/03/2026
IV
4.5g
Q8
Urosepsis
Checking Initial Appropriateness 
05/29/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/29/2026
05/30/2026
IV
4.5g
Q8
Urosepsis
Checking Initial Appropriateness 
05/29/2026
CEFIXIME 200MG (CAP)
05/29/2026
06/03/2026
PO
200mg
Q12
Uti
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: